Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(16.28%)
USD 0.01
(16.28%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.82 Million USD | -268.46% |
| 2022 | 1.08 Million USD | 1418.29% |
| 2021 | -82 Thousand USD | 86.4% |
| 2020 | -603 Thousand USD | -132.82% |
| 2019 | -259 Thousand USD | -12850.0% |
| 2018 | -2000.00 USD | -101.9% |
| 2017 | 105 Thousand USD | 131.34% |
| 2016 | -335 Thousand USD | -309.38% |
| 2015 | 160 Thousand USD | 134.33% |
| 2014 | -466 Thousand USD | -1209.52% |
| 2013 | 42 Thousand USD | 162.5% |
| 2012 | 16 Thousand USD | 107.48% |
| 2011 | -214 Thousand USD | 34.15% |
| 2010 | -325 Thousand USD | -160.0% |
| 2009 | -125 Thousand USD | 73.9% |
| 2008 | -479 Thousand USD | 35.96% |
| 2007 | -748 Thousand USD | 72.07% |
| 2006 | -2.67 Million USD | -231.44% |
| 2005 | -808 Thousand USD | -28.25% |
| 2004 | -630 Thousand USD | 23.17% |
| 2003 | -820 Thousand USD | -81.02% |
| 2002 | -453 Thousand USD | 79.5% |
| 2001 | -2.21 Million USD | 4.74% |
| 2000 | -2.32 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -193 Thousand USD | 21.22% |
| 2023 Q2 | -766 Thousand USD | -140.13% |
| 2023 Q1 | -319 Thousand USD | -50.47% |
| 2023 FY | -1.82 Million USD | -268.46% |
| 2023 Q4 | -245 Thousand USD | 50.1% |
| 2023 Q3 | -491 Thousand USD | 35.9% |
| 2022 Q2 | 342 Thousand USD | -54.16% |
| 2022 FY | 1.08 Million USD | 1418.29% |
| 2022 Q3 | 94 Thousand USD | -72.51% |
| 2022 Q1 | 746 Thousand USD | 153.74% |
| 2022 Q4 | -212 Thousand USD | -325.53% |
| 2021 Q4 | 294 Thousand USD | 335.2% |
| 2021 Q1 | -28 Thousand USD | 0.0% |
| 2021 Q2 | -224 Thousand USD | -700.0% |
| 2021 FY | -82 Thousand USD | 86.4% |
| 2021 Q3 | -125 Thousand USD | 44.2% |
| 2020 FY | -603 Thousand USD | -132.82% |
| 2019 FY | -259 Thousand USD | -12850.0% |
| 2018 Q2 | 15 Thousand USD | 121.13% |
| 2018 FY | -2000.00 USD | -101.9% |
| 2018 Q1 | -71 Thousand USD | 0.0% |
| 2017 Q3 | -52 Thousand USD | 17.46% |
| 2017 FY | 105 Thousand USD | 131.34% |
| 2017 Q2 | -63 Thousand USD | -61.54% |
| 2017 Q1 | -39 Thousand USD | 71.94% |
| 2016 Q3 | -124 Thousand USD | -31.91% |
| 2016 Q1 | 22 Thousand USD | 142.31% |
| 2016 Q4 | -139 Thousand USD | -12.1% |
| 2016 Q2 | -94 Thousand USD | -527.27% |
| 2016 FY | -335 Thousand USD | -309.38% |
| 2015 Q4 | -52 Thousand USD | -148.6% |
| 2015 Q3 | 107 Thousand USD | 245.16% |
| 2015 FY | 160 Thousand USD | 134.33% |
| 2015 Q2 | 31 Thousand USD | -57.53% |
| 2015 Q1 | 73 Thousand USD | 124.91% |
| 2014 FY | -466 Thousand USD | -1209.52% |
| 2014 Q2 | -63 Thousand USD | -1160.0% |
| 2014 Q1 | -5000.00 USD | 84.85% |
| 2014 Q4 | -293 Thousand USD | -179.05% |
| 2014 Q3 | -105 Thousand USD | -66.67% |
| 2013 Q1 | 55 Thousand USD | -9.84% |
| 2013 Q2 | 5000.00 USD | -90.91% |
| 2013 FY | 42 Thousand USD | 162.5% |
| 2013 Q4 | -33 Thousand USD | -320.0% |
| 2013 Q3 | 15 Thousand USD | 200.0% |
| 2012 Q2 | -9000.00 USD | 57.14% |
| 2012 Q1 | -21 Thousand USD | 63.16% |
| 2012 FY | 16 Thousand USD | 107.48% |
| 2012 Q4 | 61 Thousand USD | 506.67% |
| 2012 Q3 | -15 Thousand USD | -66.67% |
| 2011 Q3 | -68 Thousand USD | 32.67% |
| 2011 Q2 | -101 Thousand USD | -1018.18% |
| 2011 Q1 | 11 Thousand USD | 103.78% |
| 2011 FY | -214 Thousand USD | 34.15% |
| 2011 Q4 | -57 Thousand USD | 16.18% |
| 2010 Q2 | -47 Thousand USD | -4600.0% |
| 2010 Q4 | -291 Thousand USD | -2040.0% |
| 2010 Q3 | 15 Thousand USD | 131.91% |
| 2010 Q1 | -1000.00 USD | 94.44% |
| 2010 FY | -325 Thousand USD | -160.0% |
| 2009 Q3 | -50 Thousand USD | 0.0% |
| 2009 FY | -125 Thousand USD | 73.9% |
| 2009 Q2 | -50 Thousand USD | -233.33% |
| 2009 Q4 | -18 Thousand USD | 64.0% |
| 2009 Q1 | -15 Thousand USD | 92.23% |
| 2008 FY | -479 Thousand USD | 35.96% |
| 2008 Q3 | -44 Thousand USD | 74.12% |
| 2008 Q2 | -170 Thousand USD | -132.88% |
| 2008 Q1 | -73 Thousand USD | 77.88% |
| 2008 Q4 | -193 Thousand USD | -338.64% |
| 2007 FY | -748 Thousand USD | 72.07% |
| 2007 Q4 | -330 Thousand USD | -89.66% |
| 2007 Q3 | -174 Thousand USD | -145.07% |
| 2007 Q2 | -71 Thousand USD | 58.96% |
| 2007 Q1 | -173 Thousand USD | 86.69% |
| 2006 Q1 | -351 Thousand USD | 50.14% |
| 2006 FY | -2.67 Million USD | -231.44% |
| 2006 Q4 | -1.3 Million USD | -166.94% |
| 2006 Q3 | -487 Thousand USD | 10.15% |
| 2006 Q2 | -542 Thousand USD | -54.42% |
| 2005 Q3 | 174 Thousand USD | 158.19% |
| 2005 Q4 | -704 Thousand USD | -504.6% |
| 2005 Q2 | -299 Thousand USD | -1523.81% |
| 2005 Q1 | 21 Thousand USD | 104.09% |
| 2005 FY | -808 Thousand USD | -28.25% |
| 2004 FY | -630 Thousand USD | 23.17% |
| 2004 Q2 | 79 Thousand USD | 243.48% |
| 2004 Q3 | -220 Thousand USD | -378.48% |
| 2004 Q4 | -513 Thousand USD | -133.18% |
| 2004 Q1 | 23 Thousand USD | 108.46% |
| 2003 Q2 | -692 Thousand USD | -2196.97% |
| 2003 Q1 | 33 Thousand USD | 112.84% |
| 2003 Q3 | 111 Thousand USD | 116.04% |
| 2003 FY | -820 Thousand USD | -81.02% |
| 2003 Q4 | -272 Thousand USD | -345.05% |
| 2002 Q3 | -281 Thousand USD | -286.09% |
| 2002 Q1 | -67 Thousand USD | 80.86% |
| 2002 FY | -453 Thousand USD | 79.5% |
| 2002 Q4 | -257 Thousand USD | 8.54% |
| 2002 Q2 | 151 Thousand USD | 325.37% |
| 2001 Q3 | -477 Thousand USD | 47.7% |
| 2001 Q4 | -350 Thousand USD | 26.62% |
| 2001 FY | -2.21 Million USD | 4.74% |
| 2001 Q1 | -471 Thousand USD | 0.0% |
| 2001 Q2 | -912 Thousand USD | -93.63% |
| 2000 FY | -2.32 Million USD | 0.0% |
| 2000 Q1 | -615 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Achiko AG | -8.35 Million USD | 78.205% |
| Accelera Innovations, Inc | - USD | Infinity% |
| Aspyra Inc. | 4.7 Million USD | 138.723% |
| Cannabis Sativa, Inc. | -855.85 Thousand USD | -112.77% |
| CompuMed, Inc. | -31.2 Thousand USD | -5736.164% |
| CompuGroup Medical SE & Co. KGaA | 171.25 Million USD | 101.063% |
| Cogstate Limited | 660.18 Thousand USD | 375.832% |
| CareView Communications, Inc. | -688.3 Thousand USD | -164.564% |
| Craneware plc | 19.73 Million USD | 109.228% |
| Caduceus Software Systems Corp. | -1.15 Million USD | -57.763% |
| Certive Solutions Inc. | -2.1 Million USD | 13.323% |
| Drug Free Solution, Inc. | -1.4 Million USD | -29.399% |
| DATATRAK International, Inc. | 1.87 Million USD | 196.918% |
| Strainsforpains, Inc. | -65.61 Thousand USD | -2675.492% |
| Healixa Inc. | -6.35 Million USD | 71.338% |
| Easy Technologies Inc. | - USD | Infinity% |
| eWellness Healthcare Corporation | - USD | Infinity% |
| Founders Bay Holdings | 9.02 Million USD | 120.184% |
| Health Discovery Corporation | - USD | Infinity% |
| Healthcare Integrated Technologies, Inc. | -983.56 Thousand USD | -85.144% |
| H-Source Holdings Ltd. | - USD | Infinity% |
| InterCare DX, Inc. | -789.33 USD | -230601.988% |
| IQ-AI Limited | -517.25 Thousand USD | -252.049% |
| Cannabiz Mobile, Inc. | -750.00 USD | -242700.0% |
| Mednow Inc. | -17.04 Million USD | 89.315% |
| Galileo Life Sciences, Inc. | -271.37 Thousand USD | -571.035% |
| MediXall Group, Inc. | -6.54 Million USD | 72.157% |
| Mitesco, Inc. | -2.58 Million USD | 29.601% |
| MobileSmith, Inc. | -7.81 Million USD | 76.706% |
| NantHealth, Inc. | -51.32 Million USD | 96.452% |
| OneLife Technologies Corp. | - USD | Infinity% |
| ORHub, Inc. | -12.15 Million USD | 85.024% |
| Patient Access Solutions, Inc. | -9 Million USD | 79.776% |
| Pharma-Bio Serv, Inc. | 1.11 Million USD | 262.966% |
| PPJ Healthcare Enterprises, Inc. | 74.72 Thousand USD | 2536.838% |
| Medical Cannabis Payment Solutions, Inc. | -34.1 Thousand USD | -5240.176% |
| Renalytix Plc | -29.6 Million USD | 93.85% |
| Revium Recovery Inc. | -679 Thousand USD | -168.189% |
| RYAH Group, Inc. | - USD | Infinity% |
| Carepay Inc. | 396.65 Thousand USD | 559.095% |
| Vaso Corporation | 4.19 Million USD | 143.409% |
| Vynleads, Inc. | -235.73 Thousand USD | -672.494% |